Hypothesised cutaneous sites of origin of stage III melanomas with unknown primary: A multicentre study
Hughes, M. C. B.
Grant, Megan E
Smithers, B. M.
Campana, Luca G
Green, Adèle C
AffiliationDepartment of Surgery, The Christie NHS Foundation Trust, Manchester, UK
MetadataShow full item record
AbstractBased on molecular evidence that melanomas with unknown primary (MUPs) arise from the skin, we hypothesised that sites of MUPs are disproportionately on trunk and lower limbs, sites that are not readily visible to patients and clinicians. We tested this hypothesis by inferring the anatomic site of origin of MUPs from the corresponding known cutaneous sites of melanoma patients with known primary tumours (MKPs). We analysed data from three separate cohorts of patients from Brisbane, Australia (n = 236); Manchester, UK (n = 51) and Padova, Italy (n = 33), respectively, who first presented with stage III melanoma with lymph node metastases. We matched two MKP patients to each MUP patient based on lymph node dissection (LND) site, age and sex, and imputed cutaneous sites of origin of MUPs from their two matched MKPs for study countries, giving two possible sites for each MUP per centre. Overall, results showed that MUP patients were predominantly male, and trunk was the most likely origin, comprising around a third to a half of MUPs across the three cohorts. The remaining MUP inferred sites varied by country. In the Australian cohort, the legs accounted for a third of imputed sites of MUPs, while in the UK and Italian cohorts, the most frequent site was the arms followed by the legs. Our findings suggest the need for regular and thorough skin examination on trunk and limbs, especially in males, to improve early detection of cutaneous melanoma and reduce the risk of metastatic disease at the time of presentation.
CitationClayton B, Muneeb F, Hughes MCB, Grant ME, Khosrotehrani K, Smithers BM, et al. Hypothesised cutaneous sites of origin of stage III melanomas with unknown primary: A multicentre study. International Journal of Cancer. Wiley; 2022.
JournalInternational Journal of Cancer
- Patients undergoing lymphadenectomy for stage III melanomas of known or unknown primary site do not differ in outcome.
- Authors: Hughes MC, Wright A, Barbour A, Thomas J, Smithers BM, Green AC, Khosrotehrani K
- Issue date: 2013 Dec 15
- Melanoma of unknown primary origin: a population-based study in the Netherlands.
- Authors: de Waal AC, Aben KK, van Rossum MM, Kiemeney LA
- Issue date: 2013 Feb
- Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma.
- Authors: Dutton-Regester K, Kakavand H, Aoude LG, Stark MS, Gartside MG, Johansson P, O'Connor L, Lanagan C, Tembe V, Pupo GM, Haydu LE, Schmidt CW, Mann GJ, Thompson JF, Scolyer RA, Hayward NK
- Issue date: 2013 Nov
- Melanoma patients with an unknown primary tumor site have a better outcome than those with a known primary following therapeutic lymph node dissection for macroscopic (clinically palpable) nodal disease.
- Authors: van der Ploeg AP, Haydu LE, Spillane AJ, Scolyer RA, Quinn MJ, Saw RP, Shannon KF, Stretch JR, Thompson JF
- Issue date: 2014 Sep
- Outcome after therapeutic lymph node dissection in patients with unknown primary melanoma site.
- Authors: Prens SP, van der Ploeg AP, van Akkooi AC, van Montfort CA, van Geel AN, de Wilt JH, Eggermont AM, Verhoef C
- Issue date: 2011 Dec